Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 301–400 of 999
Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
Țica, O., Khamboo, W., & Kotecha, D. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.03 · Cited by 20
Amerena, J. V., Chen, S., Sriratanasathavorn, C., Cho, J. G., Huang, D., Omar, R., Tse, H., & King, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.046 · Cited by 18
Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?
Fauchier, L., Laborie, G., Clémenty, N., & Babuty, D. (2016) · Cardiac failure review · doi:10.15420/cfr.2015:28:2 · Cited by 25
“However, the Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II (RACE II) study showed that, compared with strict rate control, lenient rate control was not inferior in terms of preventing major clinical events.(14,15) In patients with HF and reduced ejec…”
BackgroundHeart Rate Control in Patients With Chronic Atrial Fibrillation and Heart Failure
Silvet, H., Hawkins, L. A., & Jacobson, A. K. (2012) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2012.00309.x · Cited by 18
β-Blockers and Atrial Fibrillation: Hypertension and Other Medical Conditions Influencing Their Use
Dorian, P., & Angaran, P. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.09.029 · Cited by 22
Pepine, C. J. (2013) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s10628 · Cited by 17
BTKi-induced cardiovascular toxicity in CLL: Risk mitigation and management strategies
Kozarac, S., Vuković, V., Fradley, M. G., & Antic, D. A. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101268 · Cited by 18
Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Fukuzawa, M., Shiosakai, K., & Kimura, T. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.05.012 · Cited by 17
Management strategies for atrial fibrillation
Patel, P. A., Ali, N., Hogarth, A. J., & Tayebjee, M. H. (2017) · Journal of the Royal Society of Medicine · doi:10.1177/0141076816677857 · Cited by 18
“To quantify bleeding risk, the HAS-BLED score (Table 2) has been advocated in ESC guidelines due to its predictive value and its ability to identify risk factors which can be actively managed.(8) All patients being considered for anticoagulation require a formal assessment of bleeding risk.”
BackgroundMilojévic, K., Beltramini, A., Nagash, M., Muret, A., Richard, O., & Lambert, Y. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.12.010 · Cited by 22
McGrath, P., Kersten, B. P., Chilbert, M. R., Rusch, C., & Nadler, M. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.11.039 · Cited by 18
Atrial fibrillation in cardiac surgery
Baeza-Herrera, L. A., Rojas‐Velasco, G., Márquez-Murillo, M. F., Portillo-Romero, A. D. R., Medina-Paz, L., Álvarez‐Álvarez, R. J., Ramos‐Enríquez, Á., & Baranda-Tovar, F. M. (2020) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m20000068 · Cited by 18
Rodríguez‐Mañero, M., Otero-Raviña, F., García‐Seara, J., Zugaza-Gurruchaga, L., Rodríguez-García, J. M., Blanco-Rodríguez, R., Turrado, V. T., Fernández-Villaverde, J. M., Vidal-Pérez, R., & González‐Juanatey, J. R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.01.014 · Cited by 18
HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011
Link, M. S., Exner, D. V., Anderson, M. E., Ackerman, M., Al‐Ahmad, A., Knight, B. P., Markowitz, S. M., Kaufman, E. S., Haines, D. E., Asirvatham, S. J., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.008 · Cited by 16
Anguita, M. P., Bayés‐Genís, A., Cepeda, J. M., Cinza‐Sanjurjo, S., Cosín, J., Leiro, M. C., Egocheaga, I., Escobar, C., Faraudo, M., García-Pinilla, J. M., et al. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30016-9 · Cited by 24
Muñoz, D. R., Crespo‐Leiro, M. G., Lozano, I. F., Gómez, J. L. Z., Peinado, R., Manzano, L., Bagudá, J. D. J., Castillo, A. M. D., Arribas, F., & Bodes, R. S. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14488 · Cited by 15
“14,15 Combination of rate-controlling drugs when a single drug does not achieve the target resting HR and the addition of digoxin/digitoxin or amiodarone are to be considered before cardiac resynchronization therapy pacemaker (CRT-P), de fi brillator (CRT-D) or pacemaker implantation followed by…”
BackgroundJaber, J., Cirenza, C., Amaral, A., Jaber, J., Filho, J. A. O., & de Paola, Â. A. V. (2011) · Clinical Cardiology · doi:10.1002/clc.20948 · Cited by 15
Maury, P., Rollin, A., Galinier, M., & Juillière, Y. (2014) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s44919 · Cited by 21
Jost, N., Kohajda, Z., Kristóf, A., Husti, Z., Juhász, V., Kiss, L., Varró, A., Virág, L., & Baczkó, I. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796642373 · Cited by 16
“strict rate control defined as resting heart rate below 85 beats per minute (bpm) was compared with more lenient control where resting rates could be between 90-100 bpm [122].”
MethodKiuchi, S., Aikawa, H., Hisatake, S., Kabuki, T., Oka, T., Dobashi, S., Fujii, T., & Ikeda, T. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2954w · Cited by 16
“Therefore, we manage our HF patients with SVT by setting the target heart rate (HR) at ≤ 110/min based on previous reports [7].”
MethodVarma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2020.11.004 · Cited by 19
“…rate control as a treatment strategy could also be tested, as this may provide a more personalized approach rather than prior randomized trials of lenient versus strict rate control that used population level rather than personalized heart rate treatment thresholds (Van Gelder 2010).”
Background(2019) · JAMA · doi:10.1001/jama.2019.15892 · Cited by 18
Jeong, J. H., Kang, S., Lee, H. S., Lee, M. S., Son, J. M., Kwon, J. M., Lee, H. S., Choi, Y. Y., Kim, S. R., Cho, D., et al. (2024) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztae062 · Cited by 17
“4 Accordingly, current guideline recommends that prompt evaluation of LV function should precede rate control and long-term rhythm con-trol.”
Marcusohn, E., Kobo, O. M., Postnikov, M., Epstein, D., Agmon, Y., Gepstein, L., Hellman, Y., & Zukermann, R. (2021) · Cardiac failure review · doi:10.15420/cfr.2021.17 · Cited by 16
“154 Moderate to severe MR 64 (16) 17 (21) 0.”
Assessment and Management of Atrial Fibrillation in Older Adults with Frailty
Diaz, A. N. R., Troy, A. L., Kaplinskiy, V., Pritchard, A., Vani, R., Ko, D., & Orkaby, A. R. (2024) · Geriatrics · doi:10.3390/geriatrics9020050 · Cited by 22
“RACE II [60], the sole randomized trial evaluating optimal ventricular rate target in AF, evaluated 614 patients with permanent (Stage 4) AF and limited its inclusion to adults up to 80 years.”
BackgroundManagement of Atrial Fibrillation in Elderly Adults
Desai, Y. B., El‐Chami, M. F., León, A. R., & Merchant, F. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14483 · Cited by 17
“In individuals in whom a rate control strategy is used, the RACE II trial demonstrated that a lenient rate control strategy (target resting heart rate <110 beats per minute (bpm)) is as effective for symptom control as a strict rate control strategy (target resting heart rate <80 bpm), with similar quality of life.(50…”
MethodRivera‐Caravaca, J. M., Piot, O., Roldán‐Rabadán, I., Denis, A., Anguita, M. P., Mansourati, J., Cabeza, A. P., Marijon, É., García‐Seara, J., Leclercq, C., et al. (2021) · EP Europace · doi:10.1093/europace/euab202 · Cited by 15
Pezawas, T., Ristl, R., Schukro, C., & Schmidinger, H. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0879-3 · Cited by 15
“The treatment strategy of stricter heart rate control does not seem to influence QOL either [24].”
Savelieva, I., Kirchhof, P. F., Danchin, N., de Graeff, P. A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur181 · Cited by 15
Kolek, M. J., Edwards, T. L., Muhammad, R., Balouch, A., Shoemaker, M. B., Blair, M. A., Kor, K. C., Takahashi, A., Kubo, M., Roden, D. M., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.040 · Cited by 15
Wang, K.-L., Wu, C., Huang, C., Wu, T.-C., Naditch‐Brûlé, L., Steg, P. G., Lin, S., & Chiang, C. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.01.010 · Cited by 15
Personett, H. A., Smoot, D. L., Stollings, J. L., Sawyer, M., & Oyen, L. J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013512473 · Cited by 15
Acute Management of Atrial Fibrillation
Atzema, C. L., & Singh, S. M. (2017) · Cardiology Clinics · doi:10.1016/j.ccl.2017.08.008 · Cited by 16
Antiarrhythmic drugs and strategies
Nattel, S., Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00017-x · Cited by 17
Lenient Versus Strict Rate Control in Atrial Fibrillation
Wyse, D. G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.028 · Cited by 15
Chen, S., He, R., Li, W., Li, Z., Chen, B., & Feng, X. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.06.016 · Cited by 16
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
Ma, C., Wu, S., Liu, S., & Han, Y. (2024) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2024.03.009 · Cited by 21
Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation
Lau, D. H., Thiyagarajah, A., Willems, S., Rostock, T., Linz, D., Stiles, M. K., Kaye, D. M., Kalman, J. M., & Sanders, P. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.124 · Cited by 15
Supraventricular Arrhythmias: Clinical Framework and Common Scenarios for the Internist
DeSimone, C. V., Naksuk, N., & Asirvatham, S. J. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.019 · Cited by 19
Prediction of cardiac arrhythmia using deterministic probabilistic finite-state automata
Li, Z., Derksen, H., Gryak, J., Jiang, C., Gao, Z., Zhang, W., Ghanbari, H., Gunaratne, P., & Najarian, K. (2020) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.102200 · Cited by 17
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbüchel, H., Hu, Y., Chen, L. Y., Couderc, J., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab001 · Cited by 22
Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
Habel, N., de Lavallaz, J. D. F., Infeld, M. M., Koehler, J. L., Ziegler, P., Lustgarten, D. L., & Meyer, M. (2023) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2023.200182 · Cited by 16
Sim, D., Lin, W., Sindone, A. P., Yingchoncharoen, T., Prameswari, H. S., Ghazi, A. M., Pin, L. C., Teo, L. L. Y., Aw, T. C., Agbayani, M. F., et al. (2023) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2022.42 · Cited by 14
Martín, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 29
Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias
Steinberg, B. A., Schulte, P. J., Hofmann, P., Ersbøll, M. K., Alexander, J. H., Broderick-Forsgren, K., Anstrom, K. J., Granger, C. B., Piccini, J. P., Velazquez, E. J., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.02.030 · Cited by 16
Badheka, A. O., Shah, N. N., Grover, P. M., Patel, N., Chothani, A., Mehta, K. D., Singh, V., Deshmukh, A. J., Savani, G. T., Rathod, A. D., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.021 · Cited by 14
Wadke, R. (2013) · Disease-a-Month · doi:10.1016/j.disamonth.2012.12.002 · Cited by 14
Managing atrial fibrillation in the CRT patient: Controversy or consensus?
Upadhyay, G. A., & Steinberg, J. S. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.04.030 · Cited by 14
Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
Ahmad, Y., & Lip, G. Y. H. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760820 · Cited by 16
Atrial fibrillation in heart failure: drug therapies for rate and rhythm control
Tadros, R., Khairy, P., Rouleau, J. L., Talajic, M. R., Guerra, P. G., & Roy, D. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9395-6 · Cited by 13
“The question of whether AF patients benefit from strict rate control was addressed by the RACE II trial [19].”
BackgroundDrug therapies in chronic heart failure: a focus on reduced ejection fraction
Bolam, H., Morton, G., & Kalra, P. R. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-138 · Cited by 15
Hayashi, H., Abe, Y., Morita, Y., Yamaji, Y., Nakane, E., Haruna, Y., Haruna, T., & Inoko, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.12.011 · Cited by 16
Blankestijn, P. J., Carrero, J. J., Clase, C. M., Deo, R., Herzog, C. A., Kasner, S. E., PASSMAN, R. S., Pecoits‐Filho, R., Reinecke, H., Shroff, G. R., et al. (2019) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2019-23-2-18-40 · Cited by 14
Trends in Antiarrhythmic Drug Use in Denmark Over 19 Years
Poulsen, C. B., Damkjær, M., Løfgren, B., & Schmidt, M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.11.009 · Cited by 13
Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
Moschovitis, G., Johnson, L., Blum, S., Aeschbacher, S., Perna, M. L. D., Pagnamenta, A., Melchiorre, P. A. M., Benz, A. P., Kobza, R., Valentino, M. D., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001606 · Cited by 16
New-onset atrial fibrillation: an update
Omae, T., & Inada, E. (2018) · Journal of Anesthesia · doi:10.1007/s00540-018-2478-8 · Cited by 13
“However, some reports have shown no significant difference in the outcome of patients whose heart rate during AF was strictly controlled below 80 beats/min, as compared to around 100 beats/min, suggesting that the perioperative heart rate should also be maintained around 100 beats/min [98].”
Safety and Feasibility of a Nocturnal Heart Rate Elevation—Exploration of a Novel Treatment Concept
Yeshwant, S. C., Zile, M. R., Lewis, M. R., LeWinter, M. M., & Meyer, M. (2018) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2018.06.009 · Cited by 13
Atrial fibrillation: an update on management
McCallum, C., Raja, D. C., & Pathak, R. K. (2019) · Australian Prescriber · doi:10.18773/austprescr.2019.067 · Cited by 17
Prediction of Congestive Heart Failure in Patients with Non Valvular Atrial Fibrillation
Imai, K., Okura, H., Tamada, T., Fukuhara, K., Koyama, T., Kume, T., Hayashida, A., Kawamoto, T., Neishi, Y., & Yoshida, K. (2013) · Internal Medicine · doi:10.2169/internalmedicine.53.0962 · Cited by 13
The 2010 European Society of Cardiology Guidelines on the Management of Atrial Fibrillation
Lip, G. Y. H., Halperin, J. L., & Tse, H. (2011) · CHEST Journal · doi:10.1378/chest.10-2763 · Cited by 14
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Михайловна, Г. Е., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-3-6-76 · Cited by 13
Anselmino, M., Scarsoglio, S., Ridolfi, L., Ferrari, G. M. D., & Saglietto, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.844275 · Cited by 13
“A single randomized clinical trial, the Rate Control Efficacy in Permanent Atrial Fibrillation II (RACE II) (28), suggested that, in patients with permanent AF, lenient (targeting resting heart rate below 110 bpm) is not inferior to strict rate control (targeting resting heart rate below 80) both in terms of cardiovas…”
MethodThe Impact of Atrial Fibrillation Treatment Strategies on Cognitive Function
Bodagh, N., Kotadia, I., Gharaviri, A., Zelaya, F. O., Birns, J., Bhalla, A., Sommerville, P., Niederer, S., O'Neill, M. D., & Williams, S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093050 · Cited by 14
Krittayaphong, R., Boonyapisit, W., Sairat, P., & Lip, G. Y. H. (2023) · Thrombosis and Haemostasis · doi:10.1055/s-0043-1768580 · Cited by 12
Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers
Koldenhof, T., Gelder, I. C. V., Crijns, H. J. G. M., Rienstra, M., & Tieleman, R. G. (2023) · Heart · doi:10.1136/heartjnl-2023-322635 · Cited by 15
Self-citationThe reversal of cardiology practices: interventions that were tried in vain.
Prasad, V. K., & Cifu, A. S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2013.10.05 · Cited by 15
Atrial Fibrillation in Long Term Care
Rich, M. W. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.07.009 · Cited by 11
Ablation of atrial fibrillation
Wright, M. J., & Narayan, S. M. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.11.009 · Cited by 13
“tricular rate [2] and to maintain sinus rhythm [3,4].”
BackgroundNarrative Review: The Management of Acute Decompensated Heart Failure
Marik, P. E., & Flemmer, M. C. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611403260 · Cited by 13
“Furthermore, a strict rate-control strategy (resting heart rate <80 beats/min) offers no advantage over a more lenient rate-control strategy (resting heart rate <110 beats/min).(101)”
BackgroundSong, S., Ko, J. S., Lee, H. A., Choi, E., Cha, M., Kim, T., Park, J., Lee, J.-M., Kang, K., Shim, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.787869 · Cited by 13
“In the RACE II trial, lenient rate control (>110 bpm) was as effective as strict rate control in persistent AF patients (4).”
MethodIntravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure
Compagner, C. T., Wysocki, C. R., Reich, E. K., Zimmerman, L. H., & Holzhausen, J. M. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.10.001 · Cited by 12
Park, S. M., Lee, S. Y., Jung, M., Youn, J., Kim, D., Cho, J. Y., Cho, D., Hyun, J., Cho, H., Park, S., et al. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2023.0114 · Cited by 12
Recent Clinical Trials in Atrial Fibrillation in Hypertensive Patients
Manolis, A. J., Kallistratos, M. S., & Poulimenos, L. E. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0268-5 · Cited by 14
New treatment options for atrial fibrillation: towards patient tailored therapy
Smit, M. D., & Gelder, I. C. V. (2011) · Heart · doi:10.1136/heartjnl-2011-300276 · Cited by 13
“Recently, however, the RAte Control Efficacy in permanent AF (RACE II) trial showed that lenient rate controldthat is, a resting heart rate <110 beats/ min (bpm)dwas not inferior to strict rate controldthat is, a resting heart rate <80 bpm and a heart rate during moderate exercise <110 bpmdwith regard to cardiovascula…”
BackgroundShinohara, M., Wada, R., Yano, K., Akitsu, K., Koike, H., Kinoshita, T., Suzuki, T., Fujino, T., & Ikeda, T. (2020) · International Heart Journal · doi:10.1536/ihj.20-256 · Cited by 12
Management of Atrial Fibrillation
Zamani, P. L., & Verdino, R. J. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614534603 · Cited by 13
“Recently, the RACE II investigators examined the impact of ‘‘lenient’’ rate control (resting heart rate less than 110 beats per minute) versus ‘‘strict’’ rate control (resting heart rate below 80 beats per minute and less than 110 beats per minute with moderate exercise).(75,76) At the end of 3year follow-up, the leni…”
BackgroundAdvances in Atrial Fibrillation Management: A Guide for General Internists
Pham, H. N., Ibrahim, R., Hieu, T. H., Sainbayar, E., Tran, V. N., Abdelnabi, M. H., Kanaan, C. N., & Sridharan, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247846 · Cited by 16
Management of Atrial Fibrillation in Elderly Patients: A Whole New Ballgame?
Parrini, I., Lucà, F., Rao, C. M., Ceravolo, R., Gelsomino, S., Ammendolea, C., Pezzi, L., Ingianni, N., Sindaco, D. D., Murrone, A., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072328 · Cited by 16
Ezekowitz, M. D., Aikens, T. H., Nagarakanti, R., & Shapiro, T. A. (2011) · Circulation · doi:10.1161/circulationaha.110.967455 · Cited by 11
Novedades en electrofisiología cardiaca y arritmias
Hernández‐Madrid, A., Francés, R. M., & Moro, C. (2011) · Revista Española de Cardiología · doi:10.1016/s0300-8932(11)70011-2 · Cited by 11
Practice Implications of the Atrial Fibrillation Guidelines
Curtis, A. B. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.338 · Cited by 11
“Additionally, at the end of the first year of the RACE II trial, the difference in the heart rate between the lenient and strict rate-control groups was actually quite small (mean SD heart rate at rest of 86 15 and 75 12 beats/min in the lenient and strict rate-control arms, respectively).(23) The updated ACCP guideli…”
BackgroundDinh, T., Baur, L. H. B., Pisters, R., Otto Kamp, B., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Lindeboom, J.-E., Heesen, W. F., Tieleman, R. G., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305017 · Cited by 11
Self-citationMordi, I. R., Santema, B. T., Kloosterman, M., Choy, A. M., Rienstra, M., Gelder, I. C. V., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1409-x · Cited by 13
Self-citationBedford, J., Drikite, L., Corbett, M. S., Doidge, J., Ferrando-Vivas, P., Johnson, A. E. W., Rajappan, K., Mouncey, P., Harrison, D. A., Young, D., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25710 · Cited by 14
Is there a heart rate paradox in acute heart failure?
Lourenço, P., Ribeiro, A., Cunha, F. M., Pintalhão, M., Marques, P. S., Cunha, F., Silva, S., & Bettencourt, P. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.129 · Cited by 12
An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension
Nitta, D., Kinugawa, K., Imamura, T., Endo, M., Amiya, E., Inaba, T., Maki, H., Hatano, M., & Komuro, I. (2015) · International Heart Journal · doi:10.1536/ihj.15-103 · Cited by 14
Dronedarone for atrial fibrillation: How does it compare with amiodarone?
Katukuri, N., Mohmand-Borkowski, A., & Burke, J. F. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10049 · Cited by 12
Murín, J., Naditch‐Brûlé, L., Brette, S., Chiang, C., O’Neill, J., & Steg, P. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086443 · Cited by 13
Atrial Fibrillation Management in Older Heart Failure Patients: A Complex Clinical Problem
Pulignano, G., Sindaco, D. D., Tinti, M. D., Tolone, S., Minardi, G., Lax, A., & Uguccioni, M. (2016) · Heart International · doi:10.5301/heartint.5000230 · Cited by 11
A Novel Atrial Fibrillation Prediction Algorithm Applicable to Recordings from Portable Devices
Li, Z., Derksen, H., Gryak, J., Ghanbari, H., Gunaratne, P., & Najarian, K. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8513006 · Cited by 11
“The lower heart rate limit is set to 110 bpm, as this rate has proven to be an effective treatment target for AFib [8].”
BackgroundShould rhythm control be preferred in younger atrial fibrillation patients?
Chen, S., Yin, Y., & Krucoff, M. W. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9687-0 · Cited by 11
“On the other hand, the recent RACEII study showed no clinical benefit of a strict rate control versus a lenient rate control with target resting heart rates of about 115 beats per minute in terms of clinical cardiovascular events [27].”
BackgroundRate Control in Atrial Fibrillation
Aini, M., & Hollander, J. E. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_7 · Cited by 11
Suzuki, S., Motoki, H., Kanzaki, Y., Maruyama, T., Hashizume, N., Kozuka, A., Yahikozawa, K., & Kuwahara, K. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01573-5 · Cited by 11
Velt, M. J. H., Gelder, I. C. V., Crijns, H. J. G. M., Rienstra, M., & Mulder, B. A. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133669 · Cited by 11
Self-citationWaldo, A. L. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.006 · Cited by 12
Li, Y., Chen, L., Shao, Y., Zhang, M., Zhi, L., & Lu, Y. (2022) · Journal of International Medical Research · doi:10.1177/03000605221109387 · Cited by 10
Atrial fibrillation: the beat is faster than the answers
Szczech, L. A. M. (2012) · Kidney International · doi:10.1038/ki.2011.430 · Cited by 10
Patel, N. N., Chung, E. H., Mounsey, J. P., Schwartz, J., Pursell, I. W., & Gehi, A. K. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.02.022 · Cited by 12
Shuai, W., Wang, X., Hong, K., Peng, Q., Li, J., Li, P., Chen, J., Cheng, X., & Su, H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.139 · Cited by 11
Çavuşoğlu, Y., Altay, H., Ekmekçi, A., Eren, M., Küçükoğlu, M. S., Nalbantgil, S., Sarı, İ., Selçuk, T., Temizhan, A., Ural, D., et al. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6767 · Cited by 12
“Ensuring rate control in patients with AF requires adjusting the dosing frequency of the drugs, use of various drug combinations and frequent medication changes (117-119).”
Background
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.